Categories Analysis, Consumer

What to look for when McCormick & Co. (MKC) reports Q3 2023 earnings

Analysts are projecting revenue of $1.7 billion for the third quarter of 2023

Shares of McCormick & Company Inc. (NYSE: MKC) were down on Tuesday. The stock has fallen 19% over the past three months. The spices and seasonings maker is scheduled to report its third quarter 2023 earnings results on Tuesday, October 3, before market open. Here’s what to expect from the earnings report:

Revenue

Analysts are projecting revenue of $1.7 billion for the third quarter of 2023, which would represent a growth of nearly 6% from the same period last year. In the second quarter of 2023, McCormick’s sales increased 8% year-over-year to $1.66 billion.

Earnings

The consensus estimate for EPS is $0.65 which compares to $0.69 in the year-ago period. In Q2 2023, adjusted EPS increased 25% to $0.60.

Points to note

McCormick expects to benefit from consumers’ continued interest in healthy and flavorful cooking as well as the strength of its brand portfolio. In the second quarter, sales growth was fueled by pricing actions. Volume, however, declined 1% in Q2 due to the decision to discontinue low-margin business.

McCormick expects the operating environment to stabilize as the year progresses and it anticipates stable demand for its brands to continue to drive sales growth, which bodes well for the third quarter.

In Q2, the company saw sales growth across both its segments – Consumer and Flavor Solutions. This growth was driven by pricing actions but was offset by declines in volume. The condiments producer anticipates continued gains from its segments through the year helped by product innovation and marketing.

McCormick’s gross margin expanded by 310 basis points in the second quarter, driven by favorable product mix and pricing, as well as cost savings from the Comprehensive Continuous Improvement (CCI) and Global Operating Effectiveness (GOE) programs. The company expects these factors to help drive margin expansion through the year, which is a positive for the third quarter.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of suppliers and partnerships with independent

Earnings Preview: Walmart (WMT) expected to report sales and profit gains in Q1

Over the years, Walmart Inc. (NYSE: WMT) has constantly diversified while maintaining its dominance in the retail world. The company is preparing to report financial results for the first three

After a positive year, what’s in the cards for Electronic Arts (EA) in FY25

Electronic Arts (NASDAQ: EA) ended fiscal 2024 on a mixed note, reporting lower revenues and improved bottom-line performance for the fourth quarter. The stock declined following the announcement as earnings

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top